Highland Capital Management LLC grew its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 21.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,047 shares of the health services provider's stock after buying an additional 3,009 shares during the quarter. Highland Capital Management LLC's holdings in The Cigna Group were worth $4,707,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Sterling Financial Group Inc. bought a new position in The Cigna Group in the 4th quarter valued at about $4,367,000. Marks Group Wealth Management Inc boosted its stake in shares of The Cigna Group by 3,669.7% during the third quarter. Marks Group Wealth Management Inc now owns 24,013 shares of the health services provider's stock valued at $8,319,000 after purchasing an additional 23,376 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in The Cigna Group by 3.6% during the 3rd quarter. Principal Financial Group Inc. now owns 323,911 shares of the health services provider's stock worth $112,216,000 after buying an additional 11,228 shares during the period. Trinity Street Asset Management LLP lifted its position in shares of The Cigna Group by 7.1% in the 3rd quarter. Trinity Street Asset Management LLP now owns 81,411 shares of the health services provider's stock worth $28,204,000 after purchasing an additional 5,397 shares during the period. Finally, Pine Valley Investments Ltd Liability Co raised its position in shares of The Cigna Group by 28.3% in the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 15,713 shares of the health services provider's stock worth $5,444,000 after acquiring an additional 3,466 shares in the last quarter. Institutional investors own 86.99% of the company's stock.
The Cigna Group Stock Performance
CI stock traded down $22.87 during trading on Thursday, hitting $280.44. 4,126,473 shares of the company's stock traded hands, compared to its average volume of 1,701,391. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The stock has a fifty day moving average price of $296.05 and a two-hundred day moving average price of $324.99. The stock has a market capitalization of $78.00 billion, a price-to-earnings ratio of 26.44, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54.
The Cigna Group (NYSE:CI - Get Free Report) last issued its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. During the same period last year, the firm earned $6.79 earnings per share. As a group, equities analysts anticipate that The Cigna Group will post 28.5 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several research analysts have issued reports on CI shares. Piper Sandler reiterated an "overweight" rating and issued a $394.00 price target (up previously from $392.00) on shares of The Cigna Group in a report on Tuesday, November 5th. Royal Bank of Canada dropped their price objective on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Truist Financial reduced their price objective on shares of The Cigna Group from $420.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. StockNews.com cut The Cigna Group from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Finally, Barclays lifted their price target on The Cigna Group from $405.00 to $420.00 and gave the stock an "overweight" rating in a research note on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, The Cigna Group currently has an average rating of "Buy" and a consensus price target of $395.93.
Read Our Latest Stock Report on The Cigna Group
The Cigna Group Company Profile
(
Free Report)
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
Before you consider The Cigna Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Cigna Group wasn't on the list.
While The Cigna Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.